MCM4 and small cell lung carcinoma: In addition, their team also confirmed that siRNA-mediated MCM4 knockdown enhanced the sensitivity of SCLC cells to cisplatin [45], suggesting that MCM4 could be used as a therapeutic target for SCLC.